The FDA announced Monday that older antipsychotics, including thorazine and prolixin, will carry boxed warnings based on data showing that the drugs raise the risk of death when used off-label to treat behavioral symptoms in elderly dementia patients. "This is something we hope [physicians] would discuss with the families and caregivers so they can understand that there are risks to using these drugs," an FDA official said.

Related Summaries